Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2

Conditions

Lymphoma 201Precursor Cell Lymphoblastic Leukemia-Lymphoma 132Lymphoma, Non-Hodgkin 112Lymphoma, Large B-Cell, Diffuse 108Leukemia 106Lymphoma, Follicular 93Hodgkin Disease 92Burkitt Lymphoma 91Lymphoma, Mantle-Cell 87Leukemia, Lymphocytic, Chronic, B-Cell 84Lymphoma, Large-Cell, Immunoblastic 73Myelodysplastic Syndromes 63Leukemia, Myeloid, Acute 61Lymphoma, B-Cell, Marginal Zone 59Multiple Myeloma 48Dendritic Cell Sarcoma, Interdigitating 38Recurrence 33Leukemia, Myeloid, Chronic-Phase 33Myeloproliferative Disorders 32Leukemia, Myeloid, Accelerated Phase 32Neoplasms, Plasma Cell 28Blast Crisis 27Leukemia, Myelomonocytic, Chronic 25Lymphoma, Large-Cell, Anaplastic 22Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 21Waldenstrom Macroglobulinemia 20Myelodysplastic-Myeloproliferative Diseases 20Congenital Abnormalities 20Lymphoma, T-Cell, Cutaneous 19Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 19

Interventions

Cyclophosphamide 3thymoglobulin 2fludarabine phosphate 2fludarabine 2Thiotepa 2Tacrolimus 2Rituximab 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2plerixafor 1blinatumomab 1aldesleukin 1Transplantation 1Sirolimus 1Mycophenolic Acid 1Mesna 1Interleukin-2 1Cytarabine 1Clofarabine 1Busulfan 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sarcoma, Myeloid × Filgrastim × Lymphoid × Clear all
NCT02790515 2025-08-12

Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
170 enrolled
LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT02259348 2017-05-30

Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation

St. Jude Children's Research Hospital

Phase 2 Terminated
12 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡